Aβ peptides were also reduced by genetic and pharmacological avenues that increase CatB activity in mice expressing hAPP with AD-linked mutations [31, 35, 37–39, 41, 48] or wild-type hAPP [40], as well as in neural progenitor cell-derived neurons expressing mutant hAPP [41]. Here, TYRP1 is linked to Alzheimer disease.